BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 32046460)

  • 1. LncRNA BLACAT1 Is Upregulated in Cervical Squamous Cell Carcinoma (CSCC) and Predicts Poor Survival.
    Cheng H; Tian J; Wang C; Ren L; Wang N
    Reprod Sci; 2020 Feb; 27(2):585-591. PubMed ID: 32046460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of long non-coding RNA LOXL1-AS1 functions as an oncogene in cervical squamous cell carcinoma by sponging miR-21.
    Bai H; Li X; Wu S
    Arch Physiol Biochem; 2023 Feb; 129(1):143-147. PubMed ID: 32881598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking the Therapeutic Potential of LncRNA
    Liu FL; Zhang ZC; Zhou SL; Liu XL; Xu W
    Discov Med; 2024 Mar; 36(182):546-558. PubMed ID: 38531795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights on the interaction between m
    Shen G; Li F; Wang Y; Huang Y; Aizezi G; Yuan J; Ma C; Lin C
    World J Surg Oncol; 2023 Jan; 21(1):25. PubMed ID: 36710350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.
    Yu J; Yuan S; Song J; Yu S
    J Transl Med; 2023 Nov; 21(1):807. PubMed ID: 37957720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA PICSAR serves as a non-invasive biomarker for the diagnosis and prognosis of cutaneous squamous cell carcinoma.
    Lv J; Zhang W; Wang Y
    Clin Exp Med; 2021 Nov; 21(4):579-586. PubMed ID: 34043139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-23b Plays a Tumor-Suppressive Role in Cutaneous Squamous Cell Carcinoma and Targets Ras-Related Protein RRAS2.
    Sun C; Mahapatra KD; Elton J; Li C; Fernando W; Lohcharoenkal W; Lapins J; Homey B; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2023 Dec; 143(12):2386-2396. PubMed ID: 37423552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA ARHGAP5 inhibits cisplatin resistance in cervical squamous cell carcinoma by interacting with AUF1.
    Deng S; Qian L; Liu L; Liu H; Xu Z; Liu Y; Wang Y; Chen L; Zhou Y
    Cancer Sci; 2023 Apr; 114(4):1582-1595. PubMed ID: 36632741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma.
    Lin S; Sun Y; Cao C; Zhu Z; Xu Y; Liu B; Hu B; Peng T; Zhi W; Xu M; Ding W; Ren F; Ma D; Li G; Wu P
    EBioMedicine; 2023 Nov; 97():104846. PubMed ID: 37879219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
    Yan C; Ma Y; Li J; Chen X; Ma J
    Hum Vaccin Immunother; 2023 Aug; 19(2):2254239. PubMed ID: 37799074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma.
    Ou Z; Lin S; Qiu J; Ding W; Ren P; Chen D; Wang J; Tong Y; Wu D; Chen A; Deng Y; Cheng M; Peng T; Lu H; Yang H; Wang J; Jin X; Ma D; Xu X; Wang Y; Li J; Wu P
    Adv Sci (Weinh); 2022 Oct; 9(29):e2203040. PubMed ID: 35986392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance.
    Fan J; Lu F; Qin T; Peng W; Zhuang X; Li Y; Hou X; Fang Z; Yang Y; Guo E; Yang B; Li X; Fu Y; Kang X; Wu Z; Han L; Mills GB; Ma X; Li K; Wu P; Ma D; Chen G; Sun C
    Nat Genet; 2023 Dec; 55(12):2175-2188. PubMed ID: 37985817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary BLACAT1 as a non-invasive biomarker for bladder cancer.
    El Sharkawi FZ; El Sabah M; Atya HB; Khaled HM
    Mol Biol Rep; 2023 May; 50(5):4339-4345. PubMed ID: 36939965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of BLACAT1 in IL-1β-Induced Human Articular Chondrocyte Apoptosis and Extracellular Matrix Degradation via the miR-149-5p/ HMGCR Axis.
    Li Z; Wang Y; Wu Y; Liu Y; Zhao Y; Chen X; Li M; Zhao R
    Protein Pept Lett; 2022; 29(7):584-594. PubMed ID: 35657039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA BLACAT1 Accelerates Non-small Cell Lung Cancer Through Up-Regulating the Activation of Sonic Hedgehog Pathway.
    Sun J; Jia J; Yuan W; Liu S; Wang W; Ge L; Ge L; Liu XJ
    Front Oncol; 2021; 11():625253. PubMed ID: 33937028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of long non-coding RNA BLACAT1 predicts aggressive clinicopathologic characteristics and poor prognosis of glioma.
    Zhang X; Wei X; Liu J; Yang J; Jin P
    Medicine (Baltimore); 2021 Mar; 100(11):e20722. PubMed ID: 33725920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
    Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
    Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA BLACAT1/miR-519d-3p/CREB1 Axis Mediates Proliferation, Apoptosis, Migration, Invasion, and Drug-Resistance in Colorectal Cancer Progression.
    Chen R; Zhou S; Chen J; Lin S; Ye F; Jiang P
    Cancer Manag Res; 2020; 12():13137-13148. PubMed ID: 33376405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression.
    Ju ZS; Sun B; Bao D; Zhang XF
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.